Home・Список акций・Schrodinger Inc

Schrodinger Inc

Закрыт

СекторЗдравоохранение

18.14 2.37

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

17.34

Макс.

18.77

Ключевые показатели
By Trading Economics
Доход	-196M -60M
Продажи	-29M 59M
Прибыль на акцию	-0.62
Рентабельность продаж	-102.456
Сотрудники	850
EBITDA	-94M -58M

Рекомендации
By TipRanks
Рекомендации	Активная покупка
Прогноз на 12 месяцев	+13.7% upside

Дивиденды
By Acuity
Следующий отчет о доходах	4 нояб. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	178M 1.1B
Предыдущая цена открытия	15.77
Предыдущая цена закрытия	18.14

Новостные настроения

By Acuity

26%

74%

81 / 340 Рейтинг в Healthcare

Schrodinger Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

6 авг. 2026 г., 23:01 UTC

Schrodinger Inc shares declined in after-market trading, reversing gains from the previous four sessions. The stock remains above its 20-day moving average.

5 авг. 2026 г., 23:01 UTC

News

Schrodinger Inc reported second-quarter adjusted EPS of $0.08, surpassing estimates. Revenue reached $58.889 million, leading to higher after-market trading.

3 авг. 2026 г., 19:51 UTC

Correlated Moves

Schrodinger Inc shares are higher, reflecting broader market gains amid a drop in oil prices and positive sentiment in the technology sector.

31 июл. 2026 г., 19:46 UTC

Correlated Moves

Schrodinger Inc shares are lower amid declining first-quarter results and broader market pressure, despite an earlier rebound from session lows.

30 июл. 2026 г., 18:46 UTC

Correlated Moves

Schrodinger Inc. advanced during Thursday's session, supported by broader market gains despite earlier pulling back from a session high.

29 июл. 2026 г., 20:51 UTC

Correlated Moves

Schrodinger Inc shares are lower in after-market trading, influenced by a broader market downturn and rising crude oil prices amid geopolitical tensions.

28 июл. 2026 г., 23:01 UTC

Schrodinger Inc. shares declined in after-market trading, remaining below their 20-day moving average amid broader market strength and pressure on technology stocks.

27 июл. 2026 г., 22:51 UTC

Schrodinger Inc. shares are higher in after-market trading, despite remaining below their 20-day moving average amid broader market dynamics and falling crude oil prices.

24 июл. 2026 г., 15:11 UTC

Schrodinger Inc shares are declining today, continuing a downward trend since Thursday's close. A pullback in crude oil prices may be affecting investor sentiment.

20 июл. 2026 г., 15:12 UTC

Correlated Moves

Schrodinger Inc. shares are lower amid a decline in the ARK Genomic Revolution ETF and broader market pressures, despite a slight rebound earlier in the session.

Сравнение c конкурентами

Изменение цены

Schrodinger Inc Прогноз

Целевая цена

By TipRanks

13.7% рост

Прогноз на 12 месяцев

Средняя 20.25 USD 13.7%

Максимум 24 USD

Минимум 17 USD

Основано на мнении 6 аналитиков Wall Street, спрогнозировавших целевые цены для Schrodinger Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

6 ratings

Покупка

Удержание

Продажа

Основано на мнении 6 аналитиков, присваивавших рейтинги акциям Schrodinger Inc – Данные за последние 3 месяца.

Настроения

By Acuity

81 / 340Рейтинг в Здравоохранение

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.